ÂÜÀòÂÒÂ×

Mr. Tomás Dagá Gelabert has served as Director of Grifols, S.A. since April 2000 and also as Vice Secretary of the Board since May 2016. He is partner and founder of the law firm Osborne Clarke in Spain, he was the managing partner until June 2017 . Prior to joining Osborne Clarke, he worked in the corporate and tax department of Peat Marwick Mitchell & Co. in Barcelona. He is currently a member of the Board of Directors of Kiro Grifols, S.L., Araclon Biotech, S.L., Biomat USA, Inc., Chiquito Acquisition Corp., PBS Acquisition Corp., Grifols Innovation and New Technologies Limited, Talecris Plasma Resources, Inc., Grifols Diagnostic Solutions Inc. and Grifols Worldwide Operations Limited. He is also a trustee and the Secretary of the private foundation Víctor Grífols i Lucas, a trustee of the Probitas Fundación Privada foundation and the Secretary non-board member of the Board of Directors of Progenika Biopharma, S.A. Mr Dagá earned his degree in Law from the University of Barcelona (Universidad de Barcelona).